Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Aug 27, 2024; 16(8): 2555-2564
Published online Aug 27, 2024. doi: 10.4240/wjgs.v16.i8.2555
Figure 1
Figure 1 Immunohistochemical staining of transmembrane serine protease 4 in biliary tract cancer. A: Transmembrane serine protease 4 (TMPRSS4)-positive biliary tract cancer (BTC) tissues; B: TMPRSS4-positive BTC tissues; C: TMPRSS4-negative BTC tissues; D: TMPRSS4-negative BTC tissues. Original magnification: 40 × (A and C); 400 × (B and D).
Figure 2
Figure 2 Kaplan–Meier curves for all patients with biliary tract cancer classified based on the expression of transmembrane serine protease 4. A: Overall survival after surgery for all patients with biliary tract cancer (BTC), classified according to the expression of transmembrane serine protease 4 (TMPRSS4); B: Recurrence-free survival after surgery for all patients with BTC, classified according to the expression of TMPRSS4. TMPRSS4: Transmembrane serine protease 4.
Figure 3
Figure 3 Overall survival after surgery for each disease, classified according to transmembrane serine protease 4 expression. A: Perihilar cholangiocarcinoma; B: Distal cholangiocarcinoma; C: Gallbladder cancer; D: Ampulla of vater cancer. TMPRSS4: Transmembrane serine protease 4.